Evidence map›Paper›PMID 41304931›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol's Potential Inhibitory and Protective Effects.

Layla A Al-Kharashi, Amira M Badr, Reem T Atawia, Elshaymaa I Elmongy, Hanan Henidi, Rehab Ali, Awatif A Binmughram, Lian Al-Abkka, Nervana Mostafa Kamal Bayoumy, Yasmen F Mahran

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Layla A Al-KharashiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0003-3171-771X
Amira M BadrDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0003-3983-868X
Reem T AtawiaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
Elshaymaa I ElmongyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo 11795, Egypt.ORCID 0000-0003-1160-5040
Hanan HenidiResearch Department, Natural and Health Sciences Research Center, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-2434-8963
Rehab AliCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Awatif A BinmughramCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Lian Al-AbkkaCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Nervana Mostafa Kamal BayoumyPhysiology Department, College of Medicine, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0002-4285-9097
Yasmen F MahranDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0002-6306-5616

Funding

This research project was supported by Ongoing Research Program, King Saud University, Riyadh, Saudi Arabia ORF-2025-575
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute nephrotoxicitycisplatincuproptosisDLATFDX1thymol

Identifiers

PMID41304931
PMCPMC12655537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.